Financial Highlights

Year ended or at December 31
(in millions, except per share data and notional value) 2014 2013 Change

1Amounts exclude cash performance bonds and guaranty fund contributions.

22011 results include a $646 million non-cash benefit from a tax adjustment primarily due to a revaluation of our deferred tax liabilities deferred tax liabilities.

All references to volume, open interest and notional value in the text of this document exclude our TRAKRS, CDS, IRS, CME Clearing Europe and CME Europe contracts.

See the 2014 Annual Report on Form 10-K for the company's forward-looking statements and risk factors.
Income Statement Data
Total revenues $3,113 $2,936 6%
Operating income 1,768 1,637 8
Income before income taxes 1,771 1,601 11
Net income attributable to CME Group  1,127 977 15
Earnings per common share attributable to CME Group
Basic  $3.37 $2.94 15%
Diluted  3.35 2.92 15
Balance Sheet Data
Current assets1 $1,979 $3,050 (35)%
Total assets1 31,675 32,923 (4)
Current liabilities1 964 1,956 (51)
Total liabilities1 10,751 11,762 (9)
CME Group shareholders’ equity 20,923 21,155 (1)
Other Data
Total contract volume (round turn trades) 3,443 3,161 9%
Total electronic volume (round turn trades) 2,975 2,727 9
Open interest at year end (contracts) 94 84 12
Notional value of trading volume (in trillions) $1,161 $925 26
Total Contract Volume: 10 - 3,078; 11 - 3,387; 12 - 2,890; 13 - 3,161; 14 - 3,443

Total Contract Volume

(in millions of round turn trades)

Total Revenues: 10 - 3,004; 11 - 3,281; 12 - 2,915; 13 - 2,936; 14 - 3,113

Total Revenues

(in millions of dollars)

Net Income Attributable to CME Group: 10 - 951; 11 - 1,812; 12 - 896; 13 - 977; 14 - 1,127

Net Income Attributable to CME Group2

(in millions of dollars)

Dividends Declared: 10 - 0.92; 11 - 1.12; 12 - 3.70; 13 - 4.40; 14 - 3.88

Dividends Declared

(in dollars per share)

Continue to: Company Achievements in 2014